These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21266174)

  • 1. Effects of antidiabetic drugs in high-fat diet and streptozotocin-nicotinamide-induced type 2 diabetic mice.
    Tahara A; Matsuyama-Yokono A; Shibasaki M
    Eur J Pharmacol; 2011 Mar; 655(1-3):108-16. PubMed ID: 21266174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antidiabetic drugs on glucose tolerance in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic mice.
    Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Shibasaki M
    Horm Metab Res; 2008 Dec; 40(12):880-6. PubMed ID: 18819058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the combination of dipeptidyl peptidase-IV inhibitor ASP8497 and antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic mice.
    Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Hayakawa M; Shibasaki M
    Eur J Pharmacol; 2009 Mar; 605(1-3):170-6. PubMed ID: 19171131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycaemic effects of antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic rats.
    Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Shibasaki M
    Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):560-8. PubMed ID: 18793271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
    Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
    J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
    Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS
    Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the combination of SGLT2 selective inhibitor ipragliflozin and various antidiabetic drugs in type 2 diabetic mice.
    Tahara A; Takasu T; Yokono M; Imamura M; Kurosaki E
    Arch Pharm Res; 2016 Feb; 39(2):259-270. PubMed ID: 26450351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.
    Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Shiraki K; Hayakawa M; Shibasaki M
    Metabolism; 2009 Mar; 58(3):379-86. PubMed ID: 19217455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet.
    Jang SM; Yee ST; Choi J; Choi MS; Do GM; Jeon SM; Yeo J; Kim MJ; Seo KI; Lee MK
    Int Immunopharmacol; 2009 Jan; 9(1):113-9. PubMed ID: 19013541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
    Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
    Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 diabetes mice induced by high-fat diet combining with streptozotocin via suppression of hepatic gluconeogenesis.
    Li W; Zhang M; Gu J; Meng ZJ; Zhao LC; Zheng YN; Chen L; Yang GL
    Fitoterapia; 2012 Jan; 83(1):192-8. PubMed ID: 22056666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
    Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
    Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetaminophen normalizes glucose homeostasis in mouse models for diabetes.
    Shertzer HG; Schneider SN; Kendig EL; Clegg DJ; D'Alessio DA; Genter MB
    Biochem Pharmacol; 2008 Mar; 75(6):1402-10. PubMed ID: 18237716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
    Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
    Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-diabetic effects of emodin involved in the activation of PPARgamma on high-fat diet-fed and low dose of streptozotocin-induced diabetic mice.
    Xue J; Ding W; Liu Y
    Fitoterapia; 2010 Apr; 81(3):173-7. PubMed ID: 19699280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.
    Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Gadbois TM; Reaven GM
    Metabolism; 2000 Nov; 49(11):1390-4. PubMed ID: 11092499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers.
    Abdin AA; Baalash AA; Hamooda HE
    J Diabetes Complications; 2010; 24(3):168-78. PubMed ID: 19328014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans.
    Nath S; Ghosh SK; Choudhury Y
    J Pharmacol Toxicol Methods; 2017; 84():20-30. PubMed ID: 27773844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
    Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.